Aptevo Therapeutics Inc. - 8-K Filing

Aptevo files patent for Nectin-4 x PD-L1 dual-targeting backbone to expand solid tumor strategy (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $APVO

Read the full article at SEC EDGAR

More Regulatory news